Siren Biotechnology

About:

Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.

Website: https://sirenbiotechnology.com

Twitter/X: sirenbio

Top Investors: Founders Fund, Lux Capital, Artis Ventures (AV), Civilization Ventures, Innovation Endeavors

Description:

Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transforms how tumor cells are eliminated and anti-tumor immunity is stimulated.

Total Funding Amount:

$23.6M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)sirenbiotechnology.com

Founders:

Nicole Paulk

Number of Employees:

1-10

Last Funding Date:

2024-06-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai